[Feedback on clinical oncology pharmacy]

Ann Pharm Fr. 2020 Jan;78(1):70-75. doi: 10.1016/j.pharma.2019.09.002. Epub 2019 Oct 31.
[Article in French]

Abstract

The rising of oral anticancer therapies let more and more patients to be cared at home and improve their quality of life. However the toxicities of these drugs and the distance with health professionals imply that the patient needs to be more autonomous with respect to his treatment. Patients through therapeutic education programs allows them to manage side effects, to be more observant and then to subsequently benefit from the treatment. We report here, oncology clinical pharmacists experiences in some health facilities in France, presented at the 1st day of clinical oncology pharmacy (December 2017, Marseille).

Keywords: Day of oncology clinical pharmacy; Journée de Pharmacie Clinique Oncologique (JPCO); Optimal drug therapy; Optimisation thérapeutique; Oral Anticancer Therapy; Pharmaceutical follow up; Suivi Pharmaceutique; Therapeutic education; Thérapie Orale Anticancéreuse; Éducation thérapeutique.

MeSH terms

  • Academies and Institutes
  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Cancer Care Facilities
  • France / epidemiology
  • Geriatrics
  • Home Nursing
  • Humans
  • Interdisciplinary Communication
  • Medical Oncology*
  • Medication Adherence
  • Neoplasms / drug therapy*
  • Neoplasms / epidemiology
  • Neoplasms / psychology
  • Patient Care Team
  • Patient Education as Topic / organization & administration
  • Pharmacy*
  • Quality of Life
  • Referral and Consultation
  • Therapies, Investigational

Substances

  • Antineoplastic Agents